Several companies that manufacture generic drugs are talking with the Department of Justice to avoid indictments for allegedly colluding to raise their prices. They would pay fines and admit that some allegations are true, Bloomberg reports.
The big picture: These potential "deferred prosecution agreements" would only cover the federal probe, not the state-led antitrust investigation, but it could shed light on any price fixing that occurred in the generic drug marketplace.
The Trump administration is pushing ahead with its drug pricing agenda even as impeachment sucks up all the political oxygen, with plans to advance some of its most ambitious regulations and to work with Congress on legislation.
Why it matters: Drug pricing remains a huge issue that both parties want to run on in 2020. For Trump, there's a lot of pressure: His most ambitious proposals have either been tabled, are tied up in the courts or have yet to be implemented.
The Trump administration is pushing for a monthly cap on what seniors pay out-of-pocket for drugs through Medicare's pharmacy benefit to be added to a bipartisan drug pricing bill in the Senate, a senior administration official told Axios.
The big picture: The cost of prescription drugs is still a top priority of the administration, even amidst all of the impeachment furor — and the president could very much use a big win on the subject heading into the 2020 election.
Justice Ruth Bader Ginsburg was released from a hospital in Baltimore Sunday after being treated for chills and fever, Reuters reports.
Details: The 86-year-old was initially evaluated at Sibley Memorial Hospital in Washington, D.C., on Friday night before being transferred to Johns Hopkins Hospital "for further evaluation and treatment of any possible infection," per a Supreme Court statement Saturday.
